Metropolitan Life Insurance Company (MetLife)’s Douglas Elliman DOUG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,289
Closed -$2.04K 613
2024
Q1
$2.04K Sell
1,289
-643
-33% -$1.32K ﹤0.01% 2288
2023
Q4
$5.7K Sell
1,932
-2,861
-60% -$6K ﹤0.01% 2277
2023
Q3
$10.8K Hold
4,793
﹤0.01% 2175
2023
Q2
$10.6K Buy
4,793
+2,294
+92% +$6.3K ﹤0.01% 2270
2023
Q1
$7.4K Sell
2,499
-2,742
-52% -$10.9K ﹤0.01% 2241
2022
Q4
$20.3K Buy
5,241
+681
+15% +$2.72K ﹤0.01% 2001
2022
Q3
$17.8K Hold
4,560
﹤0.01% 2078
2022
Q2
$20.8K Hold
4,560
﹤0.01% 2033
2022
Q1
$31.7K Sell
4,560
-13,926
-75% -$106K ﹤0.01% 1852
2021
Q4
$202K Buy
+18,486
New +$208K ﹤0.01% 2022

Other funds holding DOUG

Metropolitan Life Insurance Company (MetLife)'s DOUG Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Douglas Elliman (DOUG) in Q2 2024, closing a stake of 1,289 shares — an estimated $2.04K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in DOUG in Q4 2021 and held it in 10 quarters. The position peaked at $202K in Q4 2021. 121 funds tracked by Wall St. Rank hold DOUG as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Douglas Elliman position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,289 Douglas Elliman shares in Q2 2024, an estimated $2.04K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Douglas Elliman in Q4 2021 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Douglas Elliman position peaked at $202K in Q4 2021.
  • 121 funds tracked by Wall St. Rank held Douglas Elliman as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.